Literature DB >> 31378557

Meditation-based mind-body therapies for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis.

Michel Sabe1, Othman Sentissi2, Stefan Kaiser3.   

Abstract

Meditation-based mind-body therapies (yoga, tai-chi, qi-gong, mindfulness) have been suggested to have a potential therapeutic effect on negative symptoms. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) examining effectiveness of yoga, tai-chi, qi-gong and mindfulness on negative symptoms of schizophrenia, using different databases and trial registries. The primary outcome was effect of mind-body therapies on negative symptoms and the secondary outcome was effect on positive symptoms. Fifteen RCTs were included in the meta-analysis (N = 1081 patients). Overall, we found a beneficial effect of mind-body interventions on negative symptoms at endpoint compared to treatment-as-usual or non-specific control interventions, but the effect was small and moderate to high heterogeneity was present. A subgroup analysis for different types of therapy revealed a significant effect of mindfulness-based and yoga interventions on negative symptoms, but heterogeneity within the yoga subgroup was high. Our results did not show an increase of positive symptoms (N = 1051). Our results suggest a potential for meditation-based mind-body therapies in the treatment of negative symptoms, in particular for mindfulness based approaches and to a lesser extent yoga. Limitations in the available comparisons do not allow concluding on a specific effect of these interventions. Overall, the currently available evidence remains limited and does not yet allow one to recommend mind-body therapies for the reduction of negative symptoms. However, the present findings justify further research on mind-body therapies for the treatment of negative symptoms.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mindfulness; Negative symptoms; Qi-gong; Schizophrenia; Tai-chi; Yoga

Year:  2019        PMID: 31378557     DOI: 10.1016/j.schres.2019.07.030

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

Review 1.  Physical Activity, Positive and Negative Symptoms of Psychosis, and General Psychopathology among People with Psychotic Disorders: A Meta-Analysis.

Authors:  Ernest Swora; Monika Boberska; Ewa Kulis; Nina Knoll; Jan Keller; Aleksandra Luszczynska
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

Review 2.  Mind-body therapies for older adults with dementia: a systematic review and meta-analysis.

Authors:  Yu Wang; Chengyao Tang; Xiaoyan Fan; Kokoro Shirai; Jia-Yi Dong
Journal:  Eur Geriatr Med       Date:  2022-04-04       Impact factor: 3.269

3.  Effects of Mind-Body Exercises on Schizophrenia: A Systematic Review With Meta-Analysis.

Authors:  Gao-Xia Wei; Lin Yang; Kellie Imm; Paul D Loprinzi; Lee Smith; Xiangyang Zhang; Qian Yu
Journal:  Front Psychiatry       Date:  2020-08-13       Impact factor: 4.157

4.  EPA guidance on treatment of negative symptoms in schizophrenia.

Authors:  S Galderisi; S Kaiser; I Bitter; M Nordentoft; A Mucci; M Sabé; G M Giordano; M Ø Nielsen; L B Glenthøj; P Pezzella; P Falkai; S Dollfus; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-03-17       Impact factor: 5.361

5.  Mindfulness, cognitive fusion, and self-compassion in patients with schizophrenia spectrum disorders-A cross-sectional study.

Authors:  Kerem Böge; Franziska Pollex; Niklas Bergmann; Inge Hahne; Marco Matthäus Zierhut; Selin Mavituna; Neil Thomas; Eric Hahn
Journal:  Front Psychiatry       Date:  2022-08-02       Impact factor: 5.435

6.  Mindfulness-based interventions for non-affective psychosis: a comprehensive systematic review and meta-analysis.

Authors:  Annie Lai King Yip; Thanos Karatzias; Wai Tong Chien
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 7.  Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia.

Authors:  Qiongqiong Wu; Xiaoyi Wang; Ying Wang; Yu-Jun Long; Jing-Ping Zhao; Ren-Rong Wu
Journal:  Neurosci Bull       Date:  2021-07-05       Impact factor: 5.203

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.